Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Martinez

Showing results (671-680 of 706) with videos related to

Pageof 71
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
The European Respiratory Journal|November 4, 2017
A simple algorithm for the identification of clinical COPD phenotypesPierre-Régis Burgel, Jean-Louis Paillasseur, Wim Janssens, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|October 15, 2020
Characteristics and Surgical Outcomes in Very Elderly Patients (≥75 years) with Renal Cell Carcinoma: Data from the Latin American Renal Cancer GroupAdrián M Garza-Gangemi, Ricardo A Castillejos-Molina, Guillermo Gueglio, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 25, 2014
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC surveyMartina Bocchetta, Samantha Galluzzi, Patrick Gavin Kehoe, et al.
Parkinsonism & Related Disorders|April 8, 2018
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patientsMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Movement Disorders Clinical Practice|May 15, 2024
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up StudyDiego Santos-García, Teresa de Deus, Carlos Cores, et al.
Brain and Behavior|November 8, 2023
Staging Parkinson's disease according to the MNCD classification correlates with caregiver burdenDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Movement Disorders Clinical Practice|October 27, 2018
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease DurationMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Pageof 71

Showing results (671-680 of 706) with videos related to

Sort By:
Pageof 71
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
The European Respiratory Journal|November 4, 2017
A simple algorithm for the identification of clinical COPD phenotypesPierre-Régis Burgel, Jean-Louis Paillasseur, Wim Janssens, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|October 15, 2020
Characteristics and Surgical Outcomes in Very Elderly Patients (≥75 years) with Renal Cell Carcinoma: Data from the Latin American Renal Cancer GroupAdrián M Garza-Gangemi, Ricardo A Castillejos-Molina, Guillermo Gueglio, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 25, 2014
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC surveyMartina Bocchetta, Samantha Galluzzi, Patrick Gavin Kehoe, et al.
Parkinsonism & Related Disorders|April 8, 2018
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patientsMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Movement Disorders Clinical Practice|May 15, 2024
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up StudyDiego Santos-García, Teresa de Deus, Carlos Cores, et al.
Brain and Behavior|November 8, 2023
Staging Parkinson's disease according to the MNCD classification correlates with caregiver burdenDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Movement Disorders Clinical Practice|October 27, 2018
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease DurationMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Pageof 71